NSE filing, NSE: SBCL. Summary written from the filing by ALFA Finder's alert engine.
Shivalik Bimetal Controls Ltd: key numbers
- Share price
- ₹1,056.80
- Market cap
- ₹6,088 Cr
- Revenue (annual)
- ₹570.9 Cr
- Net profit (annual)
- ₹95.86 Cr
- P/E (TTM)
- 57.4×Sector 51.9×
- Promoter holding
- 33.61%+0.00% QoQ
- FII holding
- 3.41%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shivalik Bimetal Controls Ltd
All →Shivalik Bimetal Controls Bonus Issue
Shivalik Bimetal added a bonus share proposal and interim dividend to its 04 November 2026 board agenda. Trading window remains closed until 06 November 2026.
Shivalik Bimetal Controls Board Meeting Date
Shivalik Bimetal Controls intimated a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. This is advance notice only; no results are reported yet.
Shivalik Bimetal Controls Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026, confirming the recent reclassification of a promoter entity.
Shivalik Bimetal Controls Other Announcement
Shareholders approved an amendment to the Articles of Association of Shivalik Bimetal Controls Limited to enable future capital raising initiatives. This is an enabling provision only.
Shivalik Bimetal Controls Annual General Meeting
Shivalik Bimetal Controls held its 42nd Annual General Meeting on September 2, 2026. The meeting transacted ordinary and special business, including the re-appointment of a director.
Shivalik Bimetal Controls Management Change
Shivalik Bimetal Controls Limited announced the sad demise of its Non-Executive Independent Director, Mr. Swarnjit Singh, on September 1, 2026.
Other regulatory approval announcements
All →John Cockerill India Regulatory Approval
John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.
Gland Pharma Regulatory Approval
Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.
City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031